Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure

Tumor Necrosis Factor/Sphingosine-1-Phosphate Signaling Augments Resistance Artery Myogenic Tone in Diabetes

(2016) Meghan Sauvé et al.   DIABETES

Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles

(2016) Kwangseok Hong et al.   JOURNAL OF PHYSIOLOGY-LONDON

Myogenic responses occur on a beat-to-beat basis in the resting human limb

(2015) Seth T. Fairfax et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Therapeutically Targeting Tumor Necrosis Factor-α/Sphingosine-1-Phosphate Signaling Corrects Myogenic Reactivity in Subarachnoid Hemorrhage

(2015) Kenji Yagi et al.   STROKE

Stretch–Activation of Angiotensin II Type 1 a Receptors Contributes to the Myogenic Response of Mouse Mesenteric and Renal Arteries

(2014) Johanna Schleifenbaum et al.   CIRCULATION RESEARCH

Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients

(2013) S Yoshida et al.   JOURNAL OF HUMAN HYPERTENSION

TNFα reverse signaling promotes sympathetic axon growth and target innervation

(2013) Lilian Kisiswa et al.   NATURE NEUROSCIENCE

Capitalizing on diversity: an integrative approach towards the multiplicity of cellular mechanisms underlying myogenic responsiveness

(2012) Darcy Lidington et al.   CARDIOVASCULAR RESEARCH

Tumor Necrosis Factor-α–Mediated Downregulation of the Cystic Fibrosis Transmembrane Conductance Regulator Drives Pathological Sphingosine-1-Phosphate Signaling in a Mouse Model of Heart Failure

(2012) Anja Meissner et al.   CIRCULATION

Proximal Cerebral Arteries Develop Myogenic Responsiveness in Heart Failure via Tumor Necrosis Factor-α–Dependent Activation of Sphingosine-1-Phosphate Signaling

(2012) Jingli Yang et al.   CIRCULATION

Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets

(2011) Pauline L Martin et al.   BRITISH JOURNAL OF PHARMACOLOGY

Existence of an Endogenous Circadian Blood Pressure Rhythm in Humans That Peaks in the Evening

(2011) Steven A. Shea et al.   CIRCULATION RESEARCH

Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis

(2011) A Sandoo et al.   JOURNAL OF HUMAN HYPERTENSION

Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms

(2010) Ana Vukolic et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial

(2010) N. B. Klarenbeek et al.   ANNALS OF THE RHEUMATIC DISEASES

Sphingosine-1-Phosphate–Dependent Activation of p38 MAPK Maintains Elevated Peripheral Resistance in Heart Failure Through Increased Myogenic Vasoconstriction

(2010) Judith Hoefer et al.   CIRCULATION RESEARCH

Transmembrane TNF- : structure, function and interaction with anti-TNF agents

(2010) T. Horiuchi et al.   RHEUMATOLOGY

The Phosphorylation Motif at Serine 225 Governs the Localization and Function of Sphingosine Kinase 1 in Resistance Arteries

(2009) Darcy Lidington et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor

(2009) Zehra Kaymakcalan et al.   CLINICAL IMMUNOLOGY

Ca2+sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response

(2009) Rosalyn P. Johnson et al.   JOURNAL OF PHYSIOLOGY-LONDON

Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction

(2008) Michael Mederos y Schnitzler et al.   EMBO JOURNAL

Involvement of Tumor Necrosis Factor-α in Angiotensin II–Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy

(2008) Srinivas Sriramula et al.   HYPERTENSION

TNF-mediated inflammatory disease

(2007) JR Bradley   JOURNAL OF PATHOLOGY